Skip to main content
. 2024 Aug 29;16(17):2889. doi: 10.3390/nu16172889

Figure 3.

Figure 3

Analysis of the endpoints. Data are presented as the mean ± SD. (A) Neutrophil count (%), (B) lymphocyte count (%), and (C) neutrophil to lymphocyte ratio (NLR) at week 12. The Mann–Whitney U test was used to calculate statistical significance. (D) Change in C-reactive protein (CRP), and (E) change in CA19-9 from baseline to week 12. The Wilcoxon test was used for calculating statistical significance. −KES, group not administered 1-kestose; +KES, group administered 1-kestose.